Therapeutic Vision’s products are designed to promote eye health and maintain vision.
Blinding cataracts develop in 80% of all dogs within the first year of the onset of diabetes mellitus. At present, vision in these dogs can only be restored by removing cataracts with surgery. Kinostat is a new, topical eye drop (aldose reductase inhibitor) that is being developed by Therapeutic Vision to prevent cataract formation in diabetic dogs. This means that vision is not lost and cataract surgery is not required!
Kinostat is currently not available for sale. We are in the process of filing paperwork required for FDA approval which is estimated to be near the end of 2017. Thank you for your interest in our product. We are striving to make this available as soon as possible to meet you diabetic dog’s needs.
While targeting oxidative pathways associated with these age related diseases suggests therapeutic potential, numerous clinical trials have shown little if any beneficial effects on cataracts when various antioxidants are orally administered. Studies show that this is related the inability of orally administered antioxidants to adequately reach the anterior segment, especially the lens. Our topical antioxidant formulation has been shown to reach the lens.